RE:RE:RE:RE:RE:RE:RE:RE:Merck knows the importance of RVV's BucillamineLOL
MF says lots of things to blow smoke up investor butts. The only institutional support is via ATM/bought deals. AT YOUR EXPENSE!
Try to stay focused on real world possibilities. Warren Buffet will not be promoting RVV on Forbes Live today.
TheTerminator1 wrote: Stop with BS Ott >>>
Excerpt form the last PR >>> Michael Frank, CEO of the Company commented, "We are focused on completing our Phase 3 study in COVID-19 with the aim to seek EUA approval from the FDA for Bucillamine in the treatment of mild to moderate COVID-19 patients, and advancing our proprietary psychedelics program in developing novel uses and delivery forms of psilocybin to treat mental health and substance abuse disorders. With our common shares listed on the OTCQB it will help us to broaden our awareness and shareholder base with institutional and retail investors in the U.S.” TheTerminator1 wrote: Is that right....Your behind on your DD or playing the stupid game
1ottrunner wrote: Institutional buyers will have ZERO to do with a penny stock.
You do know this, right?
I'm not telling you something you don't know, correct?
TheTerminator1 wrote: I will let US Institutional Buyers do all the talking if you are smart enough to know what i mean!!!
1ottrunner wrote: You made the statement. You have to prove it. You can't ask me to prove your BS wrong.
Do you think posting idiotic BS here helps the SP? Are you dumb enough to believe that you have some control over the market from Stockhouse?
TheTerminator1 wrote: Prove me wrong
1ottrunner wrote: Merck does? BS! Offer some realiable DD on this.
Why post rediculous garbage?
TheTerminator1 wrote: Lots of good new news to come for RVV shareholders
Stay connected